How to Buy Grifols Sa Stock
Grifols Sa
Grifols, S. A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions.
Grifols Sa stock last closed at $6.48, up 2.86% from the previous day, and has decreased 13.6% in one year. It has underperformed other stocks in the Drug Manufacturers - General industry by 0.25 percentage points. Grifols Sa stock is currently +22.26% from its 52-week low of $5.30, and -46.67% from its 52-week high of $12.15.
At the moment, there are 687.55M GRFS shares outstanding. The market capitalization of GRFS is $4.46B. In the past 24 hours, 3.41M GRFS shares were traded.
How to Buy Grifols Sa Stock
Not sure how to invest in Grifols Sa stock? Here's how.
- Figure out where to buy Grifols Sa stock: You need to decide on a stock brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you figure out where to buy Grifols Sa stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Fund your investment account: Choose your payment method and add your details.
- Research Grifols Sa stock: The Grifols Sa ticker symbol is GRFS. Is Grifols Sa stock a good investment? Should you buy shares of GRFS? How do GRFS's underlying business fundamentals look? Do top analysts think Grifols Sa is a good buy? Why has GRFS's stock price moved recently? (Hint: Our stock analysis website can help you figure out if GRFS is a good stock to buy).
- Execute your GRFS trade: Decide if you will purchase GRFS shares at the current market price or use a limit order to buy GRFS stock at a given price.
- Get the latest scoop on your investment in GRFS: Create a watchlist to keep tabs on your position in Grifols Sa shares.
Step 1: Figure out where to buy Grifols Sa stock
You will need a brokerage account to access the NASDAQ market and buy GRFS shares.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to world financial markets: From Tech to Healthcare, New York to London — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by signing up for an account with eToro today.
Open eToro AccountStep 2: Create your brokerage account
Now that you've selected the right brokerage, you need to fill out some personal details so you can invest in GRFS stock today.
How to Start a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to start a new brokerage account.
- Submit your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you have created your account on apps for stocks, you can securely and quickly fund your account:
Watch the tutorial below for more details transferring funds into your brokerage account.
Step 4: Research Grifols Sa stock
Once you have figured out the best place to buy Grifols Sa stock, it's crucial to analyze their stock prior to buying, so you truly wrap your head around the risk as well as the opportunity.
Grifols Sa quick stats
Grifols Sa Fundamentals
WallStreetZen was designed to help everyday investors do better fundamental analysis in less time.
You can see all of the due diligence checks on GRFS's stock page.
Is GRFS stock properly valued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge GRFS's intrinsic value.
Using relative valuations ratios:
- GRFS may be undervalued based on its P/E ratio of 66.8x, relative to Drug Manufacturers - General industry P/E ratio of 154.11x
- GRFS could be undervalued based on its P/B ratio of 0.71x, relative to Drug Manufacturers - General industry P/B ratio of 5.99x
- GRFS may be undervalued based on its PEG ratio of 0.08x
You can access additional valuation analysis on GRFS's stock here.
GRFS Financial Overview
Positive Health Checks:
- GRFS has cash burn of 313166666. It has sufficient cash and short-term investments to cover this for at least one year.
- GRFS has $720.22M in cash and short term investments. This is enough to cover its annual cash burn of $313.17M.
- There are more short-term assets than short-term liabilities on the GRFS balance sheet.
Negative Health Checks:
- There are more long-term liabilities than short-term assets on the GRFS balance sheet.
- Total GRFS debt is higher than 5 years ago, relative to shareholder equity.
- GRFS profit margin has gone down from 3.4% to 0.9% in the past year.
- GRFS has a relatively high debt to equity ratio of 2.31.
Do analysts think it's a good time to buy GRFS stock
Out of 1 Equities analysts who give recommendations on GRFS, the consensus analyst rating on GRFS is a Hold
It's important to keep in mind that analyst ratings are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are saying on the Grifols Sa stock forecast page.
GRFS Technicals
Is GRFS Making Money?
Last year, GRFS earnings were $63.78M. Over the past five year, GRFS's earnings have gone up by -36.9% per year. This was slower than the Drug Manufacturers - General industry average of 0.94%.
Last year, GRFS revenue was $7.09B. Over the past five year, GRFS's revenue has increased by 7.27% per year. This was faster than the Drug Manufacturers - General industry average of 7.16%.
Dive into GRFS's earnings and revenue performance here.
What are GRFS insiders up to?
Over the past year, executives and large shareholders at GRFS have not bought or sold any shares.
Dig into more about who owns GRFS stock here.
Does GRFS stock generate passive income?
No, Grifols Sa doesn't provide an income stream by paying out dividends.
What others are saying about GRFS
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Execute your GRFS trade
There are two main types of orders:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are usually fine. - Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at a given price, place a limit order.
Hit the Open button and eToro will place your order.
If you require additional info about buying stocks on eToro, click the helpful video below:
Step 6: Get the latest scoop on your investment in GRFS
Now that you own some shares in GRFS, you'll want to keep up with your new investment.
Put GRFS on a watchlist to track the latest developments regarding your GRFS stock.
GRFS Feed
How to Buy Stock in Grifols Sa
To reiterate, here are the 6 steps to buy Grifols Sa stock:
- Figure out where to buy Grifols Sa stock
- Create your brokerage account
- Fund your investment account
- Research Grifols Sa stock
- Execute your GRFS trade
- Get the latest scoop on your investment in GRFS
If you are looking for a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get the latest news on your investment in Grifols Sa, add GRFS to your watchlist by clicking the button below.
Other Stock Buying Guides You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.